Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer

Kim Margolin*, Michael B. Atkins, Janice P. Dutcher, Marc S. Ernstoff, John W. Smith, Joseph I. Clark, Joseph Baar, Jeffrey Sosman, Jeffrey Weber, Chetan Lathia, Janice Brunetti, Frank Cihon, Brian Schwartz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences